Quick Answer
Inspire Medical Systems, Inc. reported Operating Income Loss of $50.95 million for the year ending 2025.
- Inspire Medical Systems, Inc. showed an increase of +41.2% in Operating Income Loss from 2024 to 2025.
- This data is from Inspire Medical Systems, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: -$4.12 million | Q2 2017: -$4.38 million | Q3 2017: -$3.65 million | Q1 2018: -$5.20 million | Q2 2018: -$5.64 million | Q3 2018: -$4.65 million | Q1 2019: -$8.78 million | Q2 2019: -$8.18 million | Q3 2019: -$8.65 million | Q1 2020: -$16.44 million | Q2 2020: -$22.81 million | Q3 2020: -$9.89 million | Q1 2021: -$15.69 million | Q2 2021: -$12.54 million | Q3 2021: -$9.80 million | Q1 2022: -$16.06 million | Q2 2022: -$14.01 million | Q3 2022: -$17.19 million | Q1 2023: -$19.50 million | Q2 2023: -$16.60 million | Q3 2023: -$13.47 million | Q1 2024: -$15.22 million | Q2 2024: $5.10 million | Q3 2024: $14.32 million | Q1 2025: -$1.49 million | Q2 2025: -$3.32 million | Q3 2025: $9.64 million.
- Over the full 10 years of available data (2016 to 2025), Inspire Medical Systems, Inc.'s Operating Income Loss has grown by 395.3%.
- Historical annual values: Fiscal year 2025: $50.95 million | Fiscal year 2024: $36.08 million | Fiscal year 2023: -$40.27 million | Fiscal year 2022: -$47.59 million | Fiscal year 2021: -$39.85 million | Fiscal year 2020: -$56.21 million | Fiscal year 2019: -$34.90 million | Fiscal year 2018: -$20.38 million | Fiscal year 2017: -$16.00 million | Fiscal year 2016: -$17.25 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: